Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Metz, J; Eber, E; Resch, B.
Respiratory Syncytial Virus Infection-associated Hospitalization Rates in Infants and Children With Cystic Fibrosis.
Pediatr Infect Dis J. 2017; 36(6):545-548
Doi: 10.1097/INF.0000000000001501
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Eber Ernst
- Resch Bernhard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Infections with respiratory syncytial virus (RSV) are the leading cause for hospital admissions in infants and young children. The incidence of RSV-related hospitalizations in patients with cystic fibrosis (CF) is unclear. To date, no effective treatment for RSV infections is available. Thus, prophylaxis with the monoclonal antibody palivizumab is an important option. In a retrospective, single-center study at the Department of Pediatrics and Adolescent Medicine of the Medical University Graz, Austria, we analyzed all CF patients born between 1995 and 2012, who were admitted for respiratory problems between 1995 and 2014. We also defined a group of hypothetical RSV infections with the following criteria: admission caused by a respiratory infection during the first RSV season of life when no test for RSV was performed. Furthermore, we assessed the effectiveness of palivizumab as a prevention of RSV-related hospitalizations. A total of 51 patients with CF were identified. The RSV-related hospitalization rate for the first RSV season was 0. Two patients (3.9%) were hospitalized 3 and 4 times, respectively, caused by RSV infections. The mean age at the time of admission was 12.4 ± 2.5 years. One case (1.9%) met our criteria for hypothetical RSV infections. There was no difference in RSV-related hospitalization rates between patients who received palivizumab and those who did not. We found a low rate of RSV-related hospitalizations and could not demonstrate a benefit of palivizumab prophylaxis regarding a decrease of RSV-related hospital admissions. The role of RSV reinfections in CF patients beyond infancy appears to be underestimated.
- Find related publications in this database (using NLM MeSH Indexing)
- Adolescent -
- Antiviral Agents - therapeutic use
- Austria - epidemiology
- Child -
- Cystic Fibrosis - complications
- Cystic Fibrosis - epidemiology
- Female -
- Hospitalization - statistics & numerical data
- Humans -
- Male -
- Palivizumab - therapeutic use
- Respiratory Syncytial Virus Infections - complications
- Respiratory Syncytial Virus Infections - drug therapy
- Respiratory Syncytial Virus Infections - epidemiology
- Respiratory Syncytial Virus, Human -
- Retrospective Studies -
- Find related publications in this database (Keywords)
- Cystic fibrosis
- respiratory syncytial virus
- palivizumab
- lower respiratory tract infection